Santelife Biogenics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 10-12-2024
- Paid Up Capital ₹ 0.15 M
as on 10-12-2024
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2020)
- Profit 277.78%
(FY 2020)
- Ebitda 7937.69%
(FY 2020)
- Net Worth 27.50%
(FY 2020)
- Total Assets 860.71%
(FY 2020)
About Santelife Biogenics
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.15 M, as per Ministry of Corporate Affairs (MCA) records.
Goutam Chakraborty, Arup Saha, Partha Bhattacharya, and One other member serve as directors at the Company.
- CIN/LLPIN
U85300WB2019PTC230321
- Company No.
230321
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Feb 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Santelife Biogenics?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Goutam Chakraborty  | Director | 09-Feb-2019 | Current |
| Arup Saha | Director | 09-Feb-2019 | Current |
| Partha Bhattacharya | Director | 09-Feb-2019 | Current |
| Pravash Har | Additional Director | 14-Jun-2022 | Current |
Financial Performance and Corporate Structure Insights of Santelife Biogenics.
Santelife Biogenics Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 277.78% increase in profit. The company's net worth Soared by an impressive increase of 27.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Santelife Biogenics?
Unlock access to Santelife Biogenics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Biostige Healthcare Private LimitedActive 3 yearsGoutam Chakraborty, Arup Saha and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Santelife Biogenics?
Unlock and access historical data on people associated with Santelife Biogenics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Santelife Biogenics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Santelife Biogenics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
